Resources from the same session
Optimal first-line therapy for extensive-stage SCLC
Presenter: Charles Rudin
Session: State of the art for small cell lung cancer: Unraveling recent data
Resources:
Slides
Webcast
Leveraging SCLC subtypes and other biomarkers
Presenter: Fred Hirsch
Session: State of the art for small cell lung cancer: Unraveling recent data
Resources:
Slides
Webcast
Q&A
Presenter: Charles Rudin
Session: State of the art for small cell lung cancer: Unraveling recent data
Resources:
Webcast